Product Information

SIMVASTATIN 5 MG TABLET is a generic product labeled by Biocon Pharma Inc., priced at $0.0314 per EA under NDC 70377000114. Its NADAC has been published 415 times since Sep 12, 2018.

FDA first approved this application on Dec 20, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SIMVASTATIN 5 MG TABLET

Simvastatin
$0.0314per EA

Strength

5 mg/1

Manufacturer

Biocon Pharma Inc.

NDC

70377000114

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

SIMVASTATIN

Approval Type

Generic (ANDA)

FDA Application

ANDA078034

FDA Approved

12/20/2006

TE Code

AB

On Market Since

12/17/2015

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for SIMVASTATIN 5 MG TABLET has been published 415 times since Sep 12, 2018, and over the history we have for it it has declined 17.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0314 per EA
All-time high$0.0483 (Feb 13, 2019)
All-time low$0.0209 (Feb 22, 2023)
52-week high$0.0353
52-week low$0.0287
Median price$0.0353
Average price$0.0342
Largest weekly change+75.0% (Jul 22, 2020)
Weeks tracked415
Tracking sinceSep 12, 2018

Price History

1W

+7.6%

1M

+7.6%

3M

+7.3%

6M

+9.1%

1Y

-10.8%

3Y

-23.0%

5Y

-1.5%

All

-17.7%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of SIMVASTATIN 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SIMVASTATIN 5 MG TABLET, manufactured by Biocon Pharma Inc., is $0.0314 per EA (NDC 70377000114), effective Aug 19, 2026.

How has the price of SIMVASTATIN 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for SIMVASTATIN 5 MG TABLET has declined 17.7%. It has been tracked across 415 weekly CMS publications since Sep 12, 2018.

What are the highest and lowest recorded NADAC prices for SIMVASTATIN 5 MG TABLET?

Since Sep 12, 2018, the NADAC for SIMVASTATIN 5 MG TABLET has ranged from a low of $0.0209 (Feb 22, 2023) to a high of $0.0483 (Feb 13, 2019), with a median of $0.0353 per EA.

Are there cheaper alternatives to SIMVASTATIN 5 MG TABLET?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SIMVASTATIN 5 MG TABLET, is $0.0288 per EA — about 8% below SIMVASTATIN 5 MG TABLET.

Who manufactures SIMVASTATIN 5 MG TABLET?

SIMVASTATIN 5 MG TABLET (NDC 70377000114) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.